Omnicell Appoints COO Nnamdi Njoku As President, Effective July 1
Omnicell, Inc. (NASDAQ: OMCL ) ("Omnicell" or the "Company"), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief Operating Officer